Jonathan Fisher

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function.
  PloS one 2019 DOI: 10.1371/journal.pone.0216373
  +Save
• Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors
  Science Signaling 2019 DOI: 10.1126/scisignal.aax1872
  +Save
• Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy.
  Frontiers in immunology 2018 DOI: 10.3389/fimmu.2018.01409
  +Save
• Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.
  Molecular therapy : the journal of the American Society of Gene Therapy 2018 DOI: 10.1016/j.ymthe.2017.12.001
  +Save
• Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor.
  Molecular therapy : the journal of the American Society of Gene Therapy 2017 DOI: 10.1016/j.ymthe.2017.03.002
  +Save
• Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells.
  2016
  +Save
• Apple's ResearchKit: smart data collection for the smartphone era?
  2015 DOI: 10.1177/0141076815600673
  +Save
• Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.
  2015 DOI: 10.1158/0008-5472.can-14-3443
  +Save
• Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy.
  2015 DOI: 10.4161/2162402x.2014.973808
  +Save
• Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.
  2014 DOI: 10.1158/1078-0432.ccr-13-3464
  +Save